August 2, 2012 / 11:00 AM / 5 years ago

Becton Dickinson results miss estimates, cuts FY forecast

* Q3 EPS $1.52 vs est $1.53

* Q3 rev $1.98 bln vs est $2.02 bln

* Cuts FY12 EPS view to $5.33-$5.38

Aug 1 (Reuters) - Medical technology company Becton Dickinson & Co’s quarterly earnings missed estimates on weakness in the U.S. research market and the company cut its full-year forecast citing anticipated effects of unfavorable currency translation.

Becton Dickinson cut its full-year profit forecast from continuing operations to between $5.33 and $5.38 per share from its previous forecast of between $5.60 and $5.70.

The maker of medical tests, supplies and laboratory equipment expects full-year revenue growth of about 1 percent versus its previous view of 1 to 2 percent.

Earnings from continuing operations fell to $311.6 million, or $1.52 per share, for the third quarter, from $321.5 million, or $1.44 per share, a year earlier.

Revenue fell 1.5 percent to $1.98 billion.

Analysts on average had expected the company to earn $1.53 per share, on revenue of $2.02 billion according to Thomson Reuters I/B/E/S.

Franklin Lakes, New Jersey based-Becton’s shares closed at $75.18 on Wednesday on the Nasdaq.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below